Diagnostic efficacy of PET/CT plus brain MR imaging for detection of extrathoracic metastases in patients with lung adenocarcinoma

Journal of Korean Medical Science

Volumn 24, Issue 6, 2009, Pages 1132-1138

  Lee, Ho Yun ^a   Lee, Kyung Soo ^a   Kim, Byung Tae ^a   Cho, Young Seok ^a   Lee, Eun Jeong ^a   Yi, Chin A ^a   Chung, Myung Jin ^a   Kim, Tae Sung ^a   Kwon, O Jung ^a   Kim, Hojoong ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

Brain; Lung neoplasms; Magnetic resonance imaging; Neoplasm metastasis; Neoplasm staging; PET CT scan

Indexed keywords

ADENOCARCINOMA; ADULT; AGED; ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HUMAN; LUNG NON SMALL CELL CANCER; LUNG TUMOR; MALE; METASTASIS; METHODOLOGY; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; POSITRON EMISSION TOMOGRAPHY; RADIOGRAPHY; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; HUMANS; LUNG NEOPLASMS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEOPLASM METASTASIS; POSITRON-EMISSION TOMOGRAPHY; ROC CURVE; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, X-RAY COMPUTED; YOUNG ADULT;

EID: 75349087460     PISSN: 10118934     EISSN: 15986357     Source Type: Journal    
DOI: 10.3346/jkms.2009.24.6.1132     Document Type: Article

References (27)

1. Boring CC, Squires TS, Tong T. Cancer Statistics, 1992. CA Cancer J Clin 1992; 42: 19-38.
2. Jemal A, Thomas A, Murray T, Thun M. Cancer statistics, 2002. CA Cancer J Clin 2002; 52: 23-47.
3. The Canadian Lung Oncology Group. Investigating extrathoracic metastatic disease in patients with apparently operable lung cancer. The Canadian Lung Oncology Group. Ann Thorac Surg 2001; 71: 425-33.
4. The American Thoracic Society and the European Respiratory Society. Pretreatment evaluation of non-small-cell lung cancer. The American Thoracic Society and the European Respiratory Society Consensus Report. Am J Respir Crit Care Med 1997; 156: 320-32.
5. Shim SS, Lee KS, Kim BT, Chung MJ, Lee EJ, Han J, Choi JY, Kwon OJ, Shim YM, Kim S. Non-small cell lung cancer: prospective comparison of integrated FDG PET/CT and CT alone for preoperative staging. Radiology 2005; 236: 1011-9.
6. De Wever W, Vankan Y, Stroobants S, Verschakelen J. Detection of extrapulmonary lesions with integrated PET/CT in the staging of lung cancer. Eur Respir J 2007; 29: 995-1002.
7. Marom EM, McAdams HP. Erasmus JJ, Goodman PC, Culhane DK, Coleman RE, Herndon JE, Patz EF Jr. Staging non-small cell lung cancer with whole-body PET. Radiology 1999; 212: 803-9.
8. Mintz BJ, Tuhrim S, Alexander S, Yang WC, Shanzer S. Intracranial metastases in the initial staging of bronchogenic carcinoma. Chest 2004; 86: 850-3.
9. Newman SJ, Hansen HH. Proceedings: frequency, diagnosis, and treatment of brain metastases in 247 consecutive patients with bronchogenic carcinoma. Cancer 1974; 33: 492-6.
10. Mujoomdar A, Austin JH, Malhotra R, Powell CA, Pearson GD, Shiau MC, Raftopoulos H. Clinical predictors of metastatic disease to the brain from non-small cell lung carcinoma: primary tumor size, cell type, and lymph node metastases. Radiology 2007; 242: 882-8.
11. Kim YK, Lee KS, Kim BT, Choi JY, Kim H, Kwon OJ, Shim YM, Yi CA, Kim HY, Chung MJ. Mediastinal nodal staging of nonsmall cell lung cancer using integrated 18F-FDG PET/CT in a tuberculosisendemic country: diagnostic efficacy in 674 patients. Cancer 2007; 109: 1068-77.
12. Lee EJ, Choi JY, Lee KS, Chung HW, Lee SJ, Cho YS, Choi Y, Choe YS, Lee KH, Kwon OJ, Shim YM, Kim BT. Improving diagnostic accuracy for malignant nodes and N staging in non-small cell lung cancer using CT-corrected FDG-PET. Korean J Nucl Med 2005; 39: 231-8.
13. Hanley JA, McNeil BJ. A method comparing the areas under receiver operator characteristic curves derived from the same cases. Radiology 1983; 148: 839-43.
14. Hillers TK, Sauve MD, Guyatt GH. Analysis of published studies on the detection of extrathoracic metastases in patients presumed to have operable non-small cell lung cancer. Thorax 1994; 49: 14-9.
15. Silvestri GA, Littenberg B, Colice GL. The clinical evaluation for detecting metastatic lung cancer: a meta-analysis. Am J Respir Crit Care Med 1995; 152: 225-30.
16. Toloza EM, Harpole L, McCrory DC. Noninvasive staging of nonsmall cell lung cancer: a review of the current evidence. Chest 2003; 123: 137S-46S.
17. Jena A, Taneja S, Talwar V, Sharma JB. Magnetic resonance (MR) patterns of brain metastasis in lung cancer patients: correlation of imaging findings with symptom. J Thorac Oncol 2008; 3: 140-4.
18. Yokoi K, Kamiya N, Matsuguma H, Machida S, Hirose T, Mori K, Tominaga K. Detection of brain metastasis in potentially operable non-small cell lung cancer: a comparison of CT and MRI. Chest 1999; 115: 714-9.
19. Silvestri GA, Gould MK, Margolis ML, Tanoue LT, McCrory D, Toloza E, Detterbeck F; American College of Chest Physicians. Noninvasive staging of non-small cell lung cancer: ACCP evidencedbased clinical practice guidelines (2nd edition). Chest 2007; 132 (3 Suppl): S178-S201.
20. Sorensen JB, Hansen HH, Hansen M, Dombernowsky P. Brain metastases in adenocarcinoma of the lung: frequency, risk groups, and prognosis. J Clin Oncol 1988; 6: 1474-80.
21. Zabel A, Milker-Zabel S, Thilmann C, Zuna I, Rhein B, Wannenmacher M, Debus J. Treatment of brain metastasis in patients with non-small cell lung cancer (NSCLC) by stereotactic linac-based radiosurgery: prognostic factors. Lung Cancer 2002; 37: 87-94.
22. Ohno Y, Koyama H, Nogami M, Takenaka D, Yoshikawa T, Yoshimura M, Kotani Y, Nishimura Y, Higashino T, Sugimura K. Wholebody MR imaging vs. FDG-PET: comparison of accuracy of M-stage diagnosis for lung cancer patients. J Magn Reson Imaging 2007; 26: 498-509.
23. Yi CA, Shin KM, Lee KS, Kim BT, Kim H, Kwon OJ, Choi JY, Chung MJ. Non-small cell lung cancer staging: efficacy comparison of integrated PET/CT versus 3.0-T whole-body MR imaging. Radiology 2008; 248: 632-42.
24. Cox JD, Yesner R. Adenocarcinoma of the lung: recent results from the veterans administration lung group. Am Rev Respir Dis 1979; 120: 1025-9.
25. Cox JD, Scott CB, Byhardt RW, Emami B, Russell AH, Fu KK, Par liament MB, Komaki R, Gaspar LE. Addition of chemotherapy to radiation therapy alters failure patterns by cell type within non-small cell carcinoma of lung (NSCCL): analysis of radiation therapy oncology group (RTOG) trials. Int J Radiat Oncol Biol Phys 1999; 43: 505-9.
26. Robnett TJ, Machtay M, Stevenson JP, Algazy KM, Hahn SM. Factors affecting the risk of brain metastases after definitive chemoradiation for locally advanced non-small-cell lung carcinoma. J Clin Oncol 2001; 19: 1344-9.
27. Davis PC, Hudgins PA, Peterman SB, Hoffman JC Jr. Diagnosis of cerebral metastases: double-dose delayed CT vs contrast enhanced MR imaging. AJNR Am J Neuroradiol 1991; 12: 293-300.